Contact UsQuotation
Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Proceed to checkoutContinue shopping
TOPBioactivityChemical infoStorage&SolubilityCalculator

Neurokinin A(4-10) TFA(97559-35-8 free base)

Copy Product Info
🥰Excellent
Catalog No. TP1385
Alias Neurokinin A(4-10) TFA

Neurokinin A(4-10) TFA(97559-35-8 free base) is a tachykinin NK2 receptor agonist[1].

Neurokinin A(4-10) TFA(97559-35-8 free base)
Other Forms of Neurokinin A(4-10) TFA(97559-35-8 free base):

Neurokinin A(4-10) TFA(97559-35-8 free base)

Copy Product Info
🥰Excellent
Catalog No. TP1385Alias Neurokinin A(4-10) TFA
Neurokinin A(4-10) TFA(97559-35-8 free base) is a tachykinin NK2 receptor agonist[1].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$41In StockIn Stock
5 mg$158In StockIn Stock
10 mg$275In StockIn Stock
25 mg$453In StockIn Stock
50 mg$636In StockIn Stock
100 mg$858In StockIn Stock
200 mg$1,150In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:>99.99%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

COA

Product Introduction

Bioactivity
Description
Neurokinin A(4-10) TFA(97559-35-8 free base) is a tachykinin NK2 receptor agonist[1].
In vitro
Neurokinin A (NKA) and its truncated form NKA(4-10) are potent spasmogens of human colon circular muscle, an action mediated exclusively via tachykinin NK2 receptors. A structure-activity study of the neurokinin A (NKA) fragment NKA(4-10) is performed to investigate the importance of amino acid residues for receptor efficacy, potency and affinity at the NK2 receptor in human colon circular muscle. A high density of NK2 receptors has been demonstrated in this tissue, using in vitro autoradiography and radioligand binding[1].
SynonymsNeurokinin A(4-10) TFA
Chemical Properties
Molecular Weight880.93
FormulaC36H55F3N8O12S
SmilesCC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N.C(=O)(C(F)(F)F)O
Relative Density.no data available
SequenceAsp-Ser-Phe-Val-Gly-Leu-Met-NH2
Sequence ShortDSFVGLM
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: < 0.1 mg/mL (insoluble)

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

NK2NeurokininreceptorNeurokinin receptorNeurokinin A(410) TFA(97559358 free base)Neurokinin A(4 10) TFA(97559 35 8 free base)Neurokinin A TFA(97559-35-8 free base)Neurokinin A TFA
Related Tags: buy Neurokinin A(4-10) TFA(97559-35-8 free base) | purchase Neurokinin A(4-10) TFA(97559-35-8 free base) | Neurokinin A(4-10) TFA(97559-35-8 free base) cost | order Neurokinin A(4-10) TFA(97559-35-8 free base) | Neurokinin A(4-10) TFA(97559-35-8 free base) chemical structure | Neurokinin A(4-10) TFA(97559-35-8 free base) in vitro | Neurokinin A(4-10) TFA(97559-35-8 free base) formula | Neurokinin A(4-10) TFA(97559-35-8 free base) molecular weight
TargetMol | Logo

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.